Imaging the head and neck is only rarely practised in radiology training and is highly complex and particulate, which is why, during our discussion with Professor Birgit Ertl-Wagner, Head of MRI at the Institute for Clinical Radiology at Grosshadern Hospital, Ludwig Maximilian University, Munich, she pointed out that many radiologists are not comfortable with orientation around this area. When…
Molecular profiling is transforming brain cancer management and radiologists must get to grips with the upcoming paradigm that will affect the way they report findings. Renowned neuroradiologist Professor Anne G. Osborn from the University of Utah, School of Medicine, Salt Lake City, unveiled the latest advances in brain pathology during the Nikola Tesla Honorary Lecture last week at ECR…
The ‘MRI of the Adnexa, Essentials and Beyond’ session from at the MR 2015 symposium held in Garmisch, Austria, presented tips and tricks in clinical routine before moving to research that combines imaging and genomic data to better evaluate ovarian cancer. Report: John Brosky
SOFIA is the new automated breast tomography system developed by iVu Imaging and presented at ECR 2015 by Hitachi. The system, beyond its charming name, offers some very charming features indeed which may make SOFIA the most comfortable scanner currently available on the market.
ECR 2015 evoked Shakespeare´s repertoire as delegates were asked to ponder the ethical implications of incidental findings in large population imaging studies in Vienna. Report: Mélisande Rouger
Researchers at University Medical Center (UMC) Utrecht are developing an innovative cancer treatment with the help of a grant from Alpe d’HuZes/Dutch Cancer Society (KWF) of nearly 300,000 euros. The treatment involves the injection of radioactive beads into tumors, thereby enabling a very precise localized radiotherapy.
The term ‘cancer’ describes more than 200 different diseases and every single one needs to be clearly understood and requires, ideally, individual treatment. To do this we need to deepen our understanding the cancer genome. Report: Anja Behringer
Scientists from the German Cancer Research Center in Heidelberg and from the Medical Faculty Mannheim of Heidelberg University treated mice with a combination of a low-dose metronomic chemotherapy and an antibody against Ang-2, a regulatory protein of the blood vessel lining cells. The treated animals had significantly less metastases.
The human immune system is usually very efficient in protecting the body against diseases by eliminating pathogens as well as infected, damaged or otherwise suspicious cells. However, it often fails because tumours have developed efficient strategies that hamper the system’s ability to detect and destroy the cancer cells. Report. Ludger Weß
The world’s first gene cancer therapy study of an innovative oral vaccine is underway at the Surgical Clinic of Heidelberg University Hospital.
PBT uses a high-energy beam of particles to destroy cancer cells by more accurately targeting the affected areas and is particularly suitable for complex childhood cancers. It also increases success rates and reduces side effects, such as deafness, loss of IQ and secondary cancers.
Excising the entire cancer tumour from the stomach prevents relapses. This procedure can now be performed endoscopically. Holger Zorn reports from the Visceral Medicine 2011 Congress in Leipzig.
Uterine fibroids are the most common benign tumours in women. Treatment is only necessary if the fibroids cause pain and bleeding due to their size and position. Minimally-invasive fibroid embolisation is a gentle, efficient and long-lasting treatment for their removal, leaving the uterus intact. The first evaluations of several international long-term studies have indicated a high success rate…
Lung cancer (pulmonary carcinoma) is one of the most common cancers worldwide and the leading cause of cancer-related deaths globally. The diagnostic and therapeutic options for lung cancer have expanded significantly in recent years. Keep reading for latest developments in screening, biomarker testing, treatment innovations, and ongoing research.
